Dr Mandaviya delivers keynote address at 5th Foundation Day of National Cancer Institute, AIIMS Jhajjar
Healthcare

Dr Mandaviya delivers keynote address at 5th Foundation Day of National Cancer Institute, AIIMS Jhajjar

Launches collaborative centre for translational research in head and neck cancer

  • By IPP Bureau | February 13, 2024

ALHNS will combine resources at both institutions in order to develop joint research and education programmes which will enhance the quality of research outputs and education

Dr Mansukh Mandaviya, Union Minister for Health and Family Welfare virtually addressed the 5th Foundation Day celebration of National Cancer Institute (NCI) of AIIMS Jhajjar, here today. Ms. Christina Scott, British Deputy High Commissioner to India was also present on the occasion.

Addressing the gathering, Dr Mandaviya said, “The way NCI has progressed over the last 5 years, is a testament to the skill and dedication of the doctors, nurses and other health workers involved in the day to day functioning of the institute.” He encouraged the institute to continue delivering quality healthcare to patients.

The Union Health Minister also presided over the signing of a Collaboration Agreement between University of Liverpool and AIIMS New Delhi for “AIIMS Liverpool Collaborative Centre for Translational Research in Head and Neck Cancer – ALHNS”. The ALHNS will build upon the pre-existing collaboration and links between the Liverpool Head and Neck Centre (LNHC), University of Liverpool and the Head and Neck Cancer Unit at AIIMS New Delhi.

ALHNS will impact the care of patients with head and neck cancer by combining resources at both institutions in order to develop joint research and education programmes which will enhance the quality of research outputs and education. It also aims to develop common SOPs so as to access high quality clinical datasets and tissue repositories of two ethnically diverse populations whose cancer-causing aetiologies differ significantly (cigarette smoking, alcohol drinking and Human papillomavirus in the UK population, in contrast to smokeless tobacco products in an Indian population). ALHNS also aims to have commonly articulated strategic goals in order to deliver cutting edge medical innovation and personalized cancer treatments.

On India’s successes in the endeavor to eliminate TB by 2025, Dr Mandaviya said, “under the Prime Minister's TB Free India Campaign, every year 25 lakh TB patients of the country are provided free medicines, testing, nutrition etc., in which approximately Rs 3000 crore is spent annually. Apart from this, financial assistance of Rs 500 per month is also given to TB patients, in which Rs 2756 crore has been paid directly into the accounts of the patients in the last 5 years. He also highlighted that 10 lakh TB patients of the country are being adopted by service-minded citizens and are also distributing nutrition to them every month.  The Union Health Minister also mentioned the Sickle Cell Elimination Program of the Indian Government in which sickle cell screening of about 7 crore people will be done in 3 years and medicines for sickle cell will be made available for free, on which the government will spend about Rs 910 crore.

Upcoming E-conference

Other Related stories

Startup

Digitization